The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
Open accessAbstract
Methods to introduce targeted double-strand breaks (DSBs) into DNA enable precise genome editing by increasing the rate at which externally supplied DNA fragments are incorporated into the genome through homologous recombination. The efficiency of these methods is limited by nonhomologous end joining (NHEJ), an alternative DNA repair pathway that competes with homology-directed repair (HDR). To promote HDR at the expense of NHEJ, we targeted DNA ligase IV, a key enzyme in the NHEJ pathway, using the inhibitor Scr7. Scr7 treatment increased the efficiency of HDR-mediated genome editing, using Cas9 in mammalian cell lines and in mice for all four genes examined, up to 19-fold. This approach should be applicable to other customizable endonucleases, such as zinc finger nucleases and transcription activator-like effector nucleases, and to nonmammalian cells with sufficiently conserved mechanisms of NHEJ and HDR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Even in the presence of donor template DNA, NHEJ is the more frequent repair mechanism observed from CRISPR/Cas9 editing (Maruyama et al., 2015).”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Maruyama et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“or inhibiting the NHEJ pathway [113] have shown to be useful as means of increasing the efficiency of HDR after Cas9 cleavage.”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [113]
In the citing paper
“Although inhibiting the NHEJ pathway with gene silencing or chemical inhibitors can partially increase the efficiency of HDR pathway, the gene repair efficacy still needs to be further improved for disease therapy [82, 85].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Yang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596
Double-strand break repair: 53BP1 comes into focus
Panier, S., & Boulton, S. J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3719 · Cited by 1,168
Kamentsky, L. D., Jones, T. R., Fraser, A. N., Bray, M., Logan, D. J., Madden, K. L., Ljosa, V., Rueden, C., Eliceiri, K. W., & Carpenter, A. E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr095 · Cited by 1,002
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,000
Guernet, A. A., Mungamuri, S. K., Cartier, D., Sachidanandam, R., Jayaprakash, A. D., Adriouch, S., Vézain, M., Charbonnier, F., Rohkin, G., Coutant, S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.017 · Cited by 85
Development and Application of CRISPR/Cas in Microbial Biotechnology
Ding, W., Zhang, Y., & Shi, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00711 · Cited by 81
Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives
Staal, F. J. T., Aiuti, A., & Cavazzana, M. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00443 · Cited by 77
Recent advances in CRISPR/Cas9-mediated knock-ins in mammalian cells
Banan, M. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.11.010 · Cited by 76
5′-Modifications improve potency and efficacy of DNA donors for precision genome editing
Ghanta, K. S., Chen, Z., Mir, A., Dokshin, G. A., Krishnamurthy, P. M., Yoon, Y., Gallant, J., Xu, P., Zhang, X.-O., Ozturk, A. R., et al. (2021) · eLife · doi:10.7554/elife.72216 · Cited by 76
Generating High-Fidelity Cochlear Organoids from Human Pluripotent Stem Cells
Moore, S. T., Nakamura, T., Nie, J., Solivais, A. J., Aristizábal-Ramírez, I., Ueda, Y., Manikandan, M., Vummidi, S. R., Romano, D. R., Hoffman, J. R., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2023.06.006 · Cited by 77
Genome Editing and Its Applications in Model Organisms
Ma, D., & Liu, F. (2015) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.12.001 · Cited by 81
High-efficiency non-mosaic CRISPR-mediated knock-in and indel mutation in F0 Xenopus
Aslan, Y., Tadjuidje, E., Zorn, A. M., & Cha, S. (2017) · Development · doi:10.1242/dev.152967 · Cited by 76
Yao, X., Wang, X., Liu, J., Hu, X., Shi, L., Shen, X., Ying, W., Sun, X.-Y., Wang, X., Huang, P., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.015 · Cited by 76
Enhancement of Precise Gene Editing by the Association of Cas9 With Homologous Recombination Factors
Tran, N. T., Bashir, S., Li, X., Rossius, J., Chu, V. T., Rajewsky, K., & Kühn, R. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00365 · Cited by 77
Ma, Y., Chen, W., Zhang, X., Yu, L., Dong, W., Pan, S., Gao, S., Huang, X., & Zhang, L. (2016) · RNA Biology · doi:10.1080/15476286.2016.1185591 · Cited by 73
CRISPR/Cas9-mediated precise genome modification by a long ssDNA template in zebrafish
Bai, H., Liu, L., An, K., Lu, X., Harrison, M., Zhao, Y., Yan, R., Lu, Z., Li, S., Lin, S., et al. (2020) · BMC Genomics · doi:10.1186/s12864-020-6493-4 · Cited by 73
Treating Cystic Fibrosis with mRNA and CRISPR
Sanchez, A. D. S., Paunovska, K., Cristian, A., & Dahlman, J. E. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.137 · Cited by 75
The hidden risks of CRISPR/Cas: structural variations and genome integrity
Aussel, C., Cathomen, T., & Fuster‐García, C. (2025) · Nature Communications · doi:10.1038/s41467-025-62606-z · Cited by 72
Applications of genome editing in insects
Reid, W. R., & O’Brochta, D. A. (2015) · Current Opinion in Insect Science · doi:10.1016/j.cois.2015.11.001 · Cited by 72
Thyme, S. B., & Schier, A. F. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.072 · Cited by 72
SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV
Greco, G. E., Matsumoto, Y., Brooks, R. C., Lu, Z., Lieber, M. R., & Tomkinson, A. E. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.04.004 · Cited by 72
Glaser, A., McColl, B., & Vadolas, J. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.48 · Cited by 72
A functional genetic toolbox for human tissue-derived organoids
Sun, D., Evans, L., Perrone, F., Sokleva, V., Lim, K., Rezakhani, S., Lutolf, M., Zilbauer, M., & Rawlins, E. L. (2021) · eLife · doi:10.7554/elife.67886 · Cited by 71
Fernández‐Godino, R., Bujakowska, K. M., & Pierce, E. A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx392 · Cited by 71
Efficient Screening of CRISPR/Cas9-Induced Events in Drosophila Using a Co-CRISPR Strategy
Kane, N. S., Vora, M., Varre, K. J., & Padgett, R. W. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.036723 · Cited by 71
Recent advances in CRISPR-Cas9-based genome insertion technologies
Chen, X., Du, J., Yun, S., Xue, C., Yao, Y., & Rao, S. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102138 · Cited by 71
Gene cassette knock-in in mammalian cells and zygotes by enhanced MMEJ
Aida, T., Nakade, S., Sakuma, T., Izu, Y., Oishi, A., Mochida, K., Ishikubo, H., Usami, T., Aizawa, H., Yamamoto, T., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-3331-9 · Cited by 74
Control of gene editing by manipulation of DNA repair mechanisms
Danner, E. W., Bashir, S., Yumlu, S., Wurst, W., Wefers, B., & Kühn, R. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9688-5 · Cited by 73
Guo, Q. J., Mintier, G. A., Ma-Edmonds, M., Storton, D., Wang, X., Xiao, X., Kienzle, B. K., Zhao, D., & Feder, J. N. (2018) · Scientific Reports · doi:10.1038/s41598-018-20358-5 · Cited by 69
Suzuki, K., Yamamoto, M., Hernández‐Benítez, R., Li, Z., Wei, C., Soligalla, R. D., Aizawa, E., Hatanaka, F., Kurita, M., Reddy, P., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0213-0 · Cited by 69
Li, Z., Wang, J., Xu, J.-P., Yang, X. F., & Yang, X. F. (2023) · Military Medical Research · doi:10.1186/s40779-023-00447-x · Cited by 72
CRISPR/Cas9-Mediated Genome Editing of Epigenetic Factors for Cancer Therapy
Yao, S., He, Z., & Chen, C. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.067 · Cited by 70
Genome scale engineering techniques for metabolic engineering
Liu, R., Bassalo, M. C., Zeitoun, R. I., & Gill, R. T. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.09.013 · Cited by 71
USH2A Gene Editing Using the CRISPR System
Fuster‐García, C., García‐García, G., González-Romero, E., Jaijo, T., Sequedo, M. D., Ayuso, C., Vázquez‐Manrique, R. P., Millán, J. M., & Aller, E. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.08.003 · Cited by 70
In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies
Yanik, M., Müller, B., Song, F., Gáll, J., Wagner, F., Wende, W., Lorenz, B., & Stieger, K. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.09.001 · Cited by 73
Designed nucleases for targeted genome editing
Lee, J., Chung, J., Kim, H. M., Kim, S., & Kim, S. (2015) · Plant Biotechnology Journal · doi:10.1111/pbi.12465 · Cited by 70
APOBEC: From mutator to editor
Yang, B., Li, X., Lei, L., & Chen, J. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.04.009 · Cited by 70
Homology-Directed Repair of a Defective Glabrous Gene in Arabidopsis With Cas9-Based Gene Targeting
Hahn, F., Eisenhut, M., Mantegazza, O., & Weber, A. P. M. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00424 · Cited by 67
Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells
Ma, X., Chen, X., Jin, Y., Ge, W., Wang, W., Kong, L., Ji, J., Guo, X., Huang, J., Feng, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03760-5 · Cited by 66
Bonawitz, N. D., Ainley, W. M., Itaya, A., Chennareddy, S. R., Cicak, T., Effinger, K., Jiang, K., Mall, T. K., Marri, P. R., Samuel, J. P., et al. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.13012 · Cited by 66
Genome editing in cardiovascular diseases
Mani, I. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.021 · Cited by 66
Cooper, C. A., Challagulla, A., Jenkins, K. A., Wise, T. G., O’Neil, T. E., Morris, K. R., Tizard, M. L., & Doran, T. J. (2016) · Transgenic Research · doi:10.1007/s11248-016-0003-0 · Cited by 68
Organoid technologies meet genome engineering
Nie, J., & Hashino, E. (2017) · EMBO Reports · doi:10.15252/embr.201643732 · Cited by 69
Genome Editing in Mice Using CRISPR/Cas9 Technology
Hall, B., Cho, A., Limaye, A., Cho, K., Khillan, J. S., & Kulkarni, A. B. (2018) · Current Protocols in Cell Biology · doi:10.1002/cpcb.57 · Cited by 72
CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Rahman, M. U., Bilal, M., Shah, J. A., Kaushik, A. K., Teissèdre, P., & Kujawska, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061252 · Cited by 65
Use of gene-editing technology to introduce targeted modifications in pigs
Ryu, J., Prather, R. S., & Lee, K. (2018) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-017-0228-7 · Cited by 65
Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection
Steyer, B., Bu, Q., Cory, E., Jiang, K., Duong, S., Sinha, D., Steltzer, S. S., Gamm, D. M., Chang, Q., & Saha, K. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.004 · Cited by 68
Exosome-mediated horizontal gene transfer occurs in double-strand break repair during genome editing
Ono, R., Yasuhiko, Y., Aisaki, K., Kitajima, S., Kanno, J., & Hirabayashi, Y. (2019) · Communications Biology · doi:10.1038/s42003-019-0300-2 · Cited by 65
Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler, M., & Concordet, J. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.04.008 · Cited by 65
Barakate, A., & Stephens, J. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00765 · Cited by 64
Kulashreshtha, M., Mehta, I. S., Kumar, P., & Rao, B. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw573 · Cited by 67
Collonnier, C., Guyon‐Debast, A., Maclot, F., Mara, K., Charlot, F., & Nogué, F. (2017) · Methods · doi:10.1016/j.ymeth.2017.04.024 · Cited by 62
Motta, B. M., Pramstaller, P. P., Hicks, A. A., & Rossini, A. (2017) · Stem Cells International · doi:10.1155/2017/8960236 · Cited by 64
Devkota, S. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.9.187 · Cited by 62
Customizing the genome as therapy for the β-hemoglobinopathies.
Canver, M. C., & Orkin, S. H. (2016) · Blood · doi:10.1182/blood-2016-01-678128 · Cited by 61
Anti-GiardiaDrug Discovery: Current Status and Gut Feelings
Riches, A. G., Hart, C. J. S., Trenholme, K. R., & Skinner‐Adams, T. S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00910 · Cited by 64
An update on precision genome editing by homology-directed repair in plants
Chen, J., Li, S., He, Y., Li, J., & Xia, L. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac037 · Cited by 67
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
Fang, T., Cao, X., Ibnat, M., & Chen, G. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01570-y · Cited by 63
Porro, F., Bortolussi, G., Barzel, A., Caneva, A. D., Iaconcig, A., Vodret, S., Zentilin, L., Kay, M. A., & Muro, A. F. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707601 · Cited by 62
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
Liu, N., Zhou, L., Lin, G., Hu, Y. F., Jiao, Y., Wang, Y., Liu, J., Yang, S., & Yao, S. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.05.036 · Cited by 60
Lee, J. S., Grav, L. M., Pedersen, L. E., Lee, G. M., & Kildegaard, H. F. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26002 · Cited by 60
Beyond editing to writing large genomes
Chari, R., & Church, G. M. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.59 · Cited by 60
Current progress of genome editing in livestock
Lee, K., Uh, K., & Farrell, K. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.01.036 · Cited by 60
Zhu, L., Mon, H., Xu, J. C., Lee, J. M., & Kusakabe, T. (2015) · Scientific Reports · doi:10.1038/srep18103 · Cited by 59
Co-incident insertion enables high efficiency genome engineering in mouse embryonic stem cells
Shy, B. R., MacDougall, M. S., Clarke, R., & Merrill, B. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw685 · Cited by 59
Multiple sgRNAs with overlapping sequences enhance CRISPR/Cas9-mediated knock-in efficiency
Jang, D. E., Lee, J. Y., Lee, J. H., Koo, O. J., Bae, H. S., Jung, M. H., Bae, J. H., Hwang, W. S., Chang, Y. J., Lee, Y. H., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0037-x · Cited by 59
Idoko-Akoh, A., Taylor, L., Sang, H., & McGrew, M. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-33244-x · Cited by 62
Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches
Leal, A., Herreno-Pachón, A., Benincore-Flórez, E., Karunathilaka, A., & Tomatsu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052456 · Cited by 58
Feng, S., Xie, X., Liu, J., Li, A., Wang, Q., Guo, D., Li, S., Li, Y., Wang, Z., Guo, T., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02139-z · Cited by 59
Connecting genotypes, phenotypes and fitness: harnessing the power of CRISPR /Cas9 genome editing
Bono, J. M., Olesnicky, E. C., & Matzkin, L. M. (2015) · Molecular Ecology · doi:10.1111/mec.13252 · Cited by 61
CRISPR/Cas9-mediated genome editing in plants
Liu, X., Xie, C., Si, H., & Yang, J. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.009 · Cited by 63
Zou, Z., Huang, K. L., Wei, Y., Chen, H., Liu, Z., & Jin, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01554-1 · Cited by 58
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
Knopp, Y., Geis, F. K., Heckl, D., Horn, S., Neumann, T., Kuehle, J., Meyer, J., Fehse, B., Baum, C., Morgan, M. A., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.006 · Cited by 63
Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models
Chenouard, V., Remy, S., Tesson, L., Ménoret, S., Ouisse, L.-H., Cherifi, Y., & Anegon, I. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.615491 · Cited by 57
Improving Precise CRISPR Genome Editing by Small Molecules: Is there a Magic Potion?
Bischoff, N., Wimberger, S., Maresca, M., & Brakebusch, C. (2020) · Cells · doi:10.3390/cells9051318 · Cited by 58
Foley, R. A., Sims, R. A., Duggan, E. C., Olmedo, J. K., Ma, R., & Jonas, S. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.973326 · Cited by 60
Chemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine
Liu, K., Chen, Y., Xie, M., Li, K., & Ding, S. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.007 · Cited by 60
Chaikind, B., Bessen, J. L., Thompson, D. B., Hu, J. H., & Liu, D. R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw707 · Cited by 57
CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells
Kim, E. J., Kang, K. H., & Ju, J. H. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.198 · Cited by 58
Targeting Alzheimer's disease with gene and cell therapies
Loera‐Valencia, R., Piras, A., Ismail, M.-A.-M., Manchanda, S., Eyjolfsdottir, H., Saido, T. C., Johansson, J., Eriksdotter, M., Winblad, B. G., & Nilsson, P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12759 · Cited by 59
Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9
Stephens, C. J., Kashentseva, E. A., Everett, W., Kaliberova, L. N., & Curiel, D. T. (2018) · Gene Therapy · doi:10.1038/s41434-018-0003-1 · Cited by 57
Precision gene editing technology and applications in nephrology
WareJoncas, Z., Campbell, J. M., Martínez‐Gálvez, G., Gendron, W. A. C., Barry, M. A., Harris, P. C., Sussman, C. R., & Ekker, S. C. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0047-x · Cited by 61
CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
Yang, W., Tu, Z., Sun, Q., & Li, X. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00030 · Cited by 59
Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases
Kolli, N., Lü, M., Maiti, P., Rossignol, J., & Dunbar, G. L. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.007 · Cited by 59
A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research
Miano, J. M., Zhu, Q. M., & Lowenstein, C. J. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.304790 · Cited by 58
Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9
Takashima, S., Shinkuma, S., Fujita, Y., Nomura, T., Ujiie, H., Natsuga, K., Iwata, H., Nakamura, H., Vorobyev, A., Abe, R., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.02.015 · Cited by 57
CRISPR/Cas9-mediated knock-in of an optimized TetO repeat for live cell imaging of endogenous loci
Tasan, I., Šustáčková, G., Zhang, L., Kim, J., Sivaguru, M., HamediRad, M., Wang, Y., Genova, J., Ma, J., Belmont, A. S., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky501 · Cited by 59
Gene Therapy For Beta-Thalassemia: Updated Perspectives
Karponi, G., & Ζώγας, Ν. (2019) · The Application of Clinical Genetics · doi:10.2147/tacg.s178546 · Cited by 57
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
Huang, K. L., Zapata, D. A., Tang, Y., Teng, Y., & Li, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121876 · Cited by 61
Nürnberg, S., Zhang, H., Hand, N. J., Bauer, R. C., Saleheen, D., Reilly, M. P., & Rader, D. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306464 · Cited by 60
Rapid Screening for CRISPR-Directed Editing of the Drosophila Genome Using white Coconversion
Ge, D. T., Tipping, C., Brodsky, M. H., & Zamore, P. D. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.032557 · Cited by 55
Mao, C., Livezey, M. R., Kim, J. E., & Shapiro, D. J. (2016) · Scientific Reports · doi:10.1038/srep34753 · Cited by 57
The Hope and Hype of CRISPR-Cas9 Genome Editing
Musunuru, K. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.1713 · Cited by 59
Jann, C., Giofrè, S., Bhattacharjee, R., & Lemke, E. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00878 · Cited by 55
Genome editing in nonhuman primates: approach to generating human disease models
Chen, Y., Niu, Y., & Ji, W. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12469 · Cited by 54
SAM homeostasis is regulated by CFIm-mediated splicing of MAT2A
Scarborough, A. M., Flaherty, J. N., Hunter, O. V., Liu, K., Kumar, A., Xing, C., Tu, B. P., & Conrad, N. K. (2021) · eLife · doi:10.7554/elife.64930 · Cited by 54
CRISPR: History and perspectives to the future
Kozovská, Z., Rajcaniova, S., Munteanu, P., Dzacovska, S., & Demková, L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111917 · Cited by 60
Shams, F., Bayat, H., Mohammadian, O., Mahboudi, S., Vahidnezhad, H., Soosanabadi, M., & Rahimpour, A. (2022) · Bioimpacts · doi:10.34172/bi.2022.23871 · Cited by 53
Snaps and mends: DNA breaks and chromosomal translocations
Javadekar, S. M., & Raghavan, S. C. (2015) · FEBS Journal · doi:10.1111/febs.13311 · Cited by 53
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field
He, Z., Men, K., Qin, Z., Yang, Y., Xu, T., & Wei, Y.-Q. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9033-0 · Cited by 55
Vartak, S. V., Swarup, H. A., Gopalakrishnan, V., Gopinatha, V. K., Ropars, V., Nambiar, M., John, F., Kothanahally, S. K. S., Kumari, R., Kumari, N., et al. (2018) · FEBS Journal · doi:10.1111/febs.14661 · Cited by 53
A Defect in DNA Ligase4 Enhances the Frequency of TALEN-Mediated Targeted Mutagenesis in Rice
Nishizawa‐Yokoi, A., Čermák, T., Hoshino, T., Sugimoto, K., Saika, H., Mori, A., Osakabe, K., Hamada, M., Katayose, Y., Starker, C. G., et al. (2015) · PLANT PHYSIOLOGY · doi:10.1104/pp.15.01542 · Cited by 52
A Review of CRISPR-Based Genome Editing: Survival, Evolution and Challenges
Ahmad, H. I., Ahmad, M. J., Asif, A. R., Adnan, M., Iqbal, M. K., Mehmood, K., Muhammad, S. A., Bhuiyan, A. A., Elokil, A., Du, X., et al. (2018) · Current Issues in Molecular Biology · doi:10.21775/cimb.028.047 · Cited by 52
Bollen, Y., Post, J. B., Koo, B., & Snippert, H. J. G. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky571 · Cited by 53
Metadata
- Authors
- Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Ploegh, Hidde L
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2015-03-23
- Volume
- 33
- Issue
- 5
- Pages
- 538-542
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4618510
- OpenAlex
- W2008147758
- Cited by
- 1,137
- References
- 32
- Citations by year
- 2026: 39 · 2025: 58 · 2024: 62 · 2023: 67 · 2022: 108 · 2021: 101 · 2020: 117 · 2019: 122 · 2018: 125 · 2017: 139 · 2016: 143 · 2015: 55
- FWCI
- 66.47
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-02-05)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI087879)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, genome editing efficiency, non-homologous end joining, homology-directed repair, DNA ligase IV, DNA double-strand break repair, zinc finger nucleases, TALEN
- MeSH terms
- DNA Ligase ATP, Animals, Cell Line, DNA Repair, Genetic Engineering, DNA Ligases, Pyrimidines, Schiff Bases, Zinc Fingers, Genome, Mice, DNA Breaks, Double-Stranded, Homologous Recombination, DNA End-Joining Repair, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review